Business
Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a
About this update from Sangamo Therapeutics, Inc.
[{"type":"text","content":" BRISBANE, Calif.--(BUSINESS WIRE)--\nSangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13th at 5:20pm EST.\n\nThe virtual session will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.\n\nAbout Sangamo Therapeutics \n\nSangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210105005148/en/\n\nInvestor Relations & Media Inquiries\nAron Feingold\n628.252.7494\[email protected]\n\nSource: Sangamo Therapeutics, Inc.","length":2721,"tagName":"div"}]